Anthropic Puts Claude Inside Drug Labs, Cutting Review Time by 89%

Anthropic details Claude's work across six biotech partnerships and its own in-house drug programs, with early wins in CAR-T, allergies, and regulatory paperwork.

Read the full story at AlphaSignal ↗

Timeline · 1 report

2026-10-27 20:27 · AlphaSignal
Anthropic Puts Claude Inside Drug Labs, Cutting Review Time by 89%

More stories

Anthropic reveals plans for blockbuster IPO — Sky News Technology
Frontier AI labs say their models refuted the Exponential Time Hypothesis. What does that mean? — TechCrunch AI
Anthropic details early drug development work with six partners and says it has acquired Mithril, a one-person company working on muscular dystrophy (Anthropic) — Techmeme
Anthropic's IPO filing shows soaring sales and steep losses — France 24 — Artificial Intelligence
How Anthropic ships the #1 LLM in the World safely: Separating the Brain from the Hands — Latent Space
Meta announces $95B offering to fund AI — Semafor Technology
Moonshot apologises after Kimi K3.1 Pro roll-out stumbles as promotional scrutiny widens — South China Morning Post Tech
Anthropic's Claude bypassed a paywall to access Georgia voter data without authorization — Axios AI+

Get the daily brief of stories like this at 6:30 every morning →